Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...

Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...

Stock analysts at Leerink Partnrs lowered their FY2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now ...

17."At eight years old, I got my period. Obviously concerned about how young I was, my mom took me to the doctor. The doctor ...

KBC Group NV boosted its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 53.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,151 shares of the company’s ...

Citi analyst David Lebowitz adjusted the price target on Incyte Corporation (NASDAQ:INCY) shares to $88 from the previous $97 while retaining a Buy rating on the stock. Currently trading at $68.30, ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Filming is underway on My Secret Santa, a brand-new live-action romantic comedy that will likely be part of Netflix’s 2025 Christmas lineup. To celebrate, Netflix has announced four new cast members.